Caption Management »

Keros Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0M 18k 58.07
2024-03-31 $3.1M 47k 66.20
2022-09-30 $753k 20k 37.65

More positions owned by Caption Management

Citigroup Com New Call Option (C)
Capri Holdings SHS Call Option (CPRI)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Verizon Communications Put Option (VZ)
Albertsons Cos Common Stock Call Option (ACI)
United States Steel Corporation Call Option (X)
Frontier Communications Pare Call Option (FYBR)
Celestica Call Option (CLS)
AmerisourceBergen Call Option (COR)
Alphabet Cap Stk Cl C Put Option (GOOG)
Verisign Call Option (VRSN)
Vistra Energy Call Option (VST)
Tapestry Call Option (TPR)
Arcellx Common Stock Call Option (ACLX)
Royal Caribbean Cruises Call Option (RCL)

View all positions for Caption Management

Top funds holding Keros Therapeutics

BlackRock
BlackRock
Vanguard Group
Darwin Global Management
T. Rowe Price Associates
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Leucadia National Corporation
TCG Crossover Management
Holocene Advisors
Woodline Partners
Geode Capital Management
Citadel Advisors
Braidwell

View all funds holding Keros Therapeutics